Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC1632 Cycluc7

Cyclic alkylaminoluciferin substrate for firefly luciferase

1393650-89-9
DCC1633 Cym50374

Novel S1PR4 antagonist

1314212-81-1
DCC1634 Cym50775

Novel non-peptidic NPBWR1 (GPR7) antagonist

DCC1635 Cym51317

Novel short-acting KOR antagonist

DCC1636 cyp11b1-in-44

Potent and selective human CYP11B1 inhibitor

1373311-09-1
DCC1637 Cyp1a1 Inhibitor 8a

Novel potent and selective CYP1A1 inhibitor, antagonizing B[a]P mediated activation of aromatic hydrocarbon receptor (AhR) in yeast cells, and protecting human cells from CYP1A1-mediated B[a]P toxicity in human cells

159429-58-0
DCC1638 Cyp3a4-effector 1

Novel covalent allosteric CYP3A4-effector

DCC1639 Cyp51/hdac-in-15j

Novel fungal lanosterol 14α-demethylase (CYP51)/histone deacetylase dual inhibitor, blocking ergosterol biosynthesis and HDAC catalytic activity in fungus, suppressing the function of efflux pump, yeast-to-hypha morphological transition, and biofilm forma

DCC1640 Cypd Inhibitor C-9

Novel CypD inhibitor, binding strongly to CypD and attenuating mitochondrial and cellular perturbation insulted by Aß and calcium stress

1572646-93-5
DCC1641 Cypd-in-29

Novel non-peptidic inhibitor of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction

1115335-95-9
DCC1642 Cyp-in-15

Novel potent tri-vector cyclophilin inhibitor

DCC1643 Cyslabdan

Inhibitor of Pentaglycine Interpeptide Bridge Synthesis

956507-17-8
DCC1644 Cys-oct

NRAS inhibitor, targeting the post-translational S-palmitoyl modification of NRAS, causing a dose-dependent decrease in NRAS palmitoylation and inhibiting downstream signaling in melanoma cells with an activating mutation in NRAS

DCC1645 cystamine-tacrine Dimer

Inhibitor of cholinesterase activity, β-amyloid aggregation and Ca overload; Novel multi-target-directed ligand (MTDL); Activator of kinase 1 and 2 (ERK1/2) and Akt/protein kinase B (PKB) pathways

1402703-27-8
DCC1646 Cysteine Protease Inhibitor

Inhibitor of cysteine protease

921625-62-9
DCC1647 Cz-01127

Unique first-in-class antibiotic, being more effective at killing pathogenic methicillin resistant Staphylococcus aureus (MRSA) bacteria than two clinical gold-standard antibiotics-vancomycin and gentamicin

DCC1648 Cz-01179

Unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by Acinetobacter baumannii

DCC1649 Czc-13788

Highly potent and selective H4R antagonist

1035226-29-9
DCC1650 Czc-25146 Hydrochloride

Novel potent, selective and metabolically stable LRRK2 inhibitor

1330003-04-7
DCC1651 D011-2120

Novel antiviral agent, blocking microtubule polymerization, disrupting the Golgi complex and inhibiting viral trafficking to the plasma membrane during virus egress

620931-39-7
DCC1652 D153249

Promoter of spinal muscular atrophy (SMA)

DCC1653 D264-0698

Novel ERK2 inhibitor

Page 1296 / Total 1557 FirstPrevNextLastGoto